Rifabutin Recruiting Phase 2 Trials for Pulmonary Tuberculosis (TB) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02256696Assessing PA-824 for Tuberculosis (the APT Trial)